LA Private

Uncategorized

High stakes as the ‘Magnificent Seven’ stocks release quarterly figures

Crunch week this week and next, as the six of the so-called “Magnificent Seven” stocks – Apple, Microsoft, Alphabet, Amazon, Nvidia, and Meta Platforms – release their latest quarterly figures. Tesla released its results last week and didn’t impress – a 44% slide in earnings from a year ago saw a 15% slump in the

High stakes as the ‘Magnificent Seven’ stocks release quarterly figures Read More »

Surging bond yields pressuring shares, Mid East dilemma for central banks, Risk of rate hike

Dr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses developments in investment markets over the past week, economic activity trackers, major global economic events and Australian economic events. Investment markets and key developments over the past week Global share markets fell over the last week on worries about an escalation of

Surging bond yields pressuring shares, Mid East dilemma for central banks, Risk of rate hike Read More »

BlueScope Steel downgrades 1st half earnings amidst softening demand

BlueScope Steel (ASX:BSL) has, at long last, downgraded first-half earnings, weeks after US-based steel rivals revealed cuts to their forecasts and actuals due to weakening margins and spreads as demand softens. The company informed the market on Friday that December half earnings are expected to be in the range of $620 million to $670 million,

BlueScope Steel downgrades 1st half earnings amidst softening demand Read More »

Stocks of the Hour: Way2VAT, Liontown Resources, Chimeric Therapeutics

Way2VAT (ASX:W2V) has announced that their operations will be unaffected by the current situation in Israel. The corporate headquarters in Tel Aviv remains open and functioning normally with staff attending, although an optional work from home policy is in place. Shares are trading 10 per cent higher at 1.1 cents. Liontown Resources (ASX:LTR) announced that

Stocks of the Hour: Way2VAT, Liontown Resources, Chimeric Therapeutics Read More »